Versant Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$319K Buy
4,878
+1,124
+30% +$76K 0.03% 458
2026
Q2
$240K Sell
3,754
-1,313
-26% -$86.3K 0.02% 554
2026
Q1
$361K Buy
5,067
+918
+22% +$72.4K 0.04% 369
2025
Q4
$340K Buy
4,149
+119
+3% +$9.27K 0.04% 324
2025
Q3
$303K Buy
4,030
+126
+3% +$9.4K 0.04% 351
2025
Q2
$289K Sell
3,904
-1,393
-26% -$97K 0.04% 337
2025
Q1
$428K Sell
5,297
-828
-14% -$71.2K 0.07% 189
2024
Q4
$479K Buy
6,125
+980
+19% +$83.3K 0.1% 99
2024
Q3
$483K Buy
5,145
+111
+2% +$9.32K 0.11% 87
2024
Q2
$392K Buy
5,034
+96
+2% +$7.83K 0.1% 87
2024
Q1
$449K Hold
4,938
– – 0.13% 77
2023
Q4
$382K Buy
4,938
+36
+0.7% +$2.52K 0.11% 84
2023
Q3
$334K Sell
4,902
-5
-0.1% -$364 0.11% 87
2023
Q2
$399K Sell
4,907
-314
-6% -$25.1K 0.13% 82
2023
Q1
$428K Buy
+5,221
New +$373K 0.14% 70

Other funds holding GEHC

Versant Capital Management's GEHC Position: Q3 2026 in Review

Versant Capital Management increased its GE HealthCare (GEHC) stake by 30% in Q3 2026, buying an estimated $76K and bringing the position to 4,878 shares worth $319K. The position accounts for 0.03% of the portfolio, ranked #458.

Versant Capital Management first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. The position peaked at $483K in Q3 2024. 1,046 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Versant Capital Management held 4,878 shares of GE HealthCare worth $319K as of Q3 2026.
  • Versant Capital Management bought 1,124 GE HealthCare shares in Q3 2026, an estimated $76K.
  • GE HealthCare made up 0.03% of Versant Capital Management's portfolio in Q3 2026, its #458 holding.
  • Versant Capital Management first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
  • Versant Capital Management's GE HealthCare position peaked at $483K in Q3 2024.
  • 1,046 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.